Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): 303371
Who filed: Henminlun
Country: India
Opposition type: Post-Grant
Opposition status: Under Examination
Date: 29-11-2019
Patent type: Compositions

Click within the document, or manually enter the page number below

Sankalp Rehabilitation Trust (Sankalp Trust), Mumbai opposition, Cabotegravir, (637/KOLNP/2013)

Countries: India Date: 2019
All-Ukrainian Network of People Living with HIV/AIDS opposition, Islatravir, (WO2017/139519 A1)

Countries: Ukraine Date: 2019
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Dolutegravir, (PI0610030-9 (US 2006/016604 - WO 2006/116764))

Countries: Brazil Date: 2019
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Atazanavir, (PI0509595-6)

Countries: Brazil Date: 2019
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, lopinavir/ritonavir (LPV/r) , (339/MUMNP/2006)

Countries: India Date: 2007
Cipla Ltd. opposition, lopinavir/ritonavir (LPV/r) , (726/MUMNP/2009 (Divisional of 339/MUMNP/2006))

Countries: India Date: 2010
Matrix Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (2474/DELNP/2009 (Divisional of 339/MUMNP/2006))

Countries: India Date: 2010
Ranbaxy Laboratories opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Countries: India Date: 2005
Cipla Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Countries: India Date: 2008
Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Countries: India Date: 2011

Henminlun Opposition, Cabotegravir, (303371)